NCT00846092 Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study Status COMPLETED Phase PHASE1
NCT00815360 Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion Status COMPLETED Phase PHASE2
NCT00801450 Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT00799227 Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00789477 DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact Status COMPLETED Phase PHASE2
NCT00780780 Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT00779142 Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies Status TERMINATED Phase NA
NCT00768040 Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema Status TERMINATED Phase PHASE2
NCT00764244 Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT00759044 Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function Status COMPLETED Phase N/A
NCT00758628 Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. Status COMPLETED Phase PHASE4
NCT00737971 Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE4
NCT00687804 A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study Status COMPLETED Phase PHASE3
NCT00687154 Observational Study of DME Following Scatter Laser Photocoagulation Status COMPLETED Phase NA
NCT00682539 Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE4
NCT00676559 Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study Status WITHDRAWN Phase PHASE1
NCT00665106 Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy Status COMPLETED Phase PHASE1
NCT00656643 Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE2